N-of-1 Trials for Closed-Loop Deep Brain Stimulation Devices

Area of Science:

• Neurology
• Biomedical Engineering
• Clinical Trials

Background:

• Closed-loop deep brain stimulation (DBS) offers personalized treatment for neurological and psychiatric disorders.
• These advanced devices carry individualized physiological and psychological risks.
• Current randomized controlled trials may not adequately capture these unique patient harms.

Purpose of the Study:

• To propose N-of-1 trial designs for evaluating phenomenological harms of closed-loop DBS.
• To advocate for N-of-1 trials to enhance personalized medicine in DBS.
• To improve informed decision-making for patients considering closed-loop DBS.

Main Methods:

• The article discusses the suitability of N-of-1 trial designs.
• It contrasts N-of-1 trials with traditional randomized controlled trials for assessing DBS risks.
• Focus is on generating phenomenological data specific to individual patient experiences.

Main Results:

• N-of-1 trials can yield valuable phenomenological data on DBS-related harms.
• This data can reveal individualized risks not typically identified in group-based trials.
• The approach aligns with the principles of precision medicine.

Conclusions:

• N-of-1 trials are a beneficial design for assessing risks associated with closed-loop DBS.
• This methodology can provide crucial information for patients and caregivers.
• Implementing N-of-1 trials can lead to more informed choices regarding DBS therapy.